859
Views
26
CrossRef citations to date
0
Altmetric
Comprehensive Review

Nutrikinetic studies of food bioactive compounds: from in vitro to in vivo approaches

, &
Pages S41-S52 | Received 05 Nov 2014, Accepted 15 Feb 2015, Published online: 01 Aug 2015

References

  • Aura AM, Martin-Lopez P, O'Leary KA, Williamson G, Oksman-Caldentey KM, Poutanen K, Santos-Buelga C. 2005. In vitro metabolism of anthocyanins by human gut microflora. Eur J Nutr 44:133–142
  • Balzer J, Rassaf T, Heiss C, Kleinbongard P, Lauer T, Merx M, Heussen N, et al. 2008. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients. A double-masked, randomized, controlled trial. J Am Coll Cardiol 51:2141–2149
  • Bischoff SC. 2011. “Gut Health”: a new objective in medicine? BMC Med 9:24
  • Blanquet-Diot S, Mahasoufi, Rambeau M, Rock E, Alric M. 2009. Digestive stability of xanthophylls exceeds that of carotenes as studied in a dynamic in vitro gastrointestinal system. J Nutr 139:876–883
  • Bocci V. 1992. The neglected organ: bacterial flora has a crucial immunostimulatory role. Perspect Biol Med 35:251–260
  • Bublin M, Radauer C, Knulst A, Wagner S, Scheiner O, Mackie AR, Mills ENC, Breitender H. 2008. Effects of gastrointestinal digestion and heating on the allergenicity of the kiwi allergens act d 1, actinidin, and act d 2, a thaumatin-like protein. Mol Nutr Food Res 52:1130–1139
  • Cadenas E, Packer L. 2002. Handbook of antioxidants. New York: Marcel Dekker, Inc
  • Cinquin C, Le Blay G, Fliss I, Lacroix C. 2004. Immobilization of infant fecal microbiota and utilization in an in vitro colonic fermentation model. Microb Ecol 48:128–138
  • Cinquin C, Le Blay G, Fliss I, Lacroix C. 2006. New three-stage in vitro model for infant colonic fermentation with immobilized fecal microbiota. FEMS Microbiol Ecol 57:324–336
  • Dall'Asta M, Calani L, Tedeschi M, Jechiu L, Brighenti F, Del Rio D. 2012. Identification of microbial metabolites derived from in vitro fecal fermentation of different polyphenolic food sources. Nutrition 28:197–203
  • de Vos WM, Castenmiller JJ, Hamer RJ, Brummer RJM. 2006. Nutridynamics – studying the dynamics of food components in products and in the consumer. Curr Opin Biotechnol 17:217–225
  • de Vos P, Faas MM, Spasojevic M, Sikkema J. 2010. Encapsulation for preservation of functionality and targeted delivery of bioactive food components. Int Dairy J 20:292–302
  • Donovan JL, Crespy V, Oliveira M, Cooper KA, Gibson BB, Williamson G. 2006. (+)-Catechin is more bioavailable than (−)-catechin: relevance to the bioavailability of catechin from cocoa. Free Radic Res 40:1029–1034
  • EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). 2011a. Scientific and technical guidance for the preparation and presentation of an application for authorisation of a health claim (revision 1). EFSA J 9:2170–2200
  • EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). 2011b. Scientific Opinion on the substantiation of a health claim related to “slowly digestible starch in starch-containing foods” and “reduction of post-prandial glycaemic responses” pursuant to Article 13(5) of Regulation (EC) No 1924/20061. EFSA J 9:2292–2307
  • EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). 2012. Scientific Opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA J 10:2809–2830
  • Englyst KN, Englyst HN, Hudson GJ, Cole TJ, Cummings JH. 1999. Rapidly available glucose in foods: an in vitro measurement that reflects the glycemic response. Am J Clin Nutr 69:448–454
  • Englyst HN, Veenstra J, Hudson GJ. 1996. Measurement of rapidly available glucose (RAG) in plant foods: a potential in vitro predictor of the glycaemic response. Br J Nutr 75:327–337
  • Evans GS, Flint N, Somers AS, Eyden B, Potten CS. 1992. The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J Cell Sci 101:219–231
  • Fatouros DG, Mullertz A. 2008. In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability. Expert Opin Drug Metab Toxicol 4:65–76
  • Fogh J, Fogh JM, Orfeo T. 1977. One hundred and twenty seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59:221–226
  • Fonti R, Latella G, Bises G, Magliocca F, Nobili F, Caprilli R. Sambuy Y. 1994. Human colonocytes in primary culture: a model to study epithelial growth, metabolism and differentiation. Int J Colorectal Dis 9:13–22
  • Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. 1966. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 50:219–244
  • Gomes A, Giri B, Kole L, Saha A, Debnath A. 2007. A crystalline compound (BM-ANF1) from the Indian toad (Bufo Melanostictus, Schneider) skin extract, induced antiproliferation and apoptosis in leukemic and hepatoma cell line involving cell cycle proteins. Toxicon 50:835–849
  • Green RJ, Murphy AS, Schulz B, Watkins BA, Ferruzzi MG. 2007. Common tea formulations modulate in vitro digestive recovery of green tea catechins. Mol Nutr Food Res 51:1152–1162
  • Gumienna M, Lasik M, Czarnecki Z. 2011. Bioconversion of grape and chokeberry wine polyphenols during simulated gastrointestinal in vitro digestion. Int J Food Sci Nutr 62:226–233
  • Harris DS, Slot JW, Geuze HJ, James DE. 1992. Polarized distribution of glucose transporter isoforms in Caco-2 cells. Pro Natl Acad Sci USA 89:7556–7560
  • Hau J, van Hoosier GL. 2003. Handbook of laboratory animal. Washington, DC: CRC Press
  • Herrero M, Simo C, García-Cañas V, Ibáñez E, Cifuentes A. 2012. Foodomics: MS-based strategies in modern food science and nutrition. Mass Spectro Rev 31:49–69
  • Hollands WJ, Hart DJ, Dainty JR, Hasselwander O, Tiihonen K, Wood R, Kroon PA. 2013. Bioavailability of epicatechin and effects on nitric oxide metabolites of an apple flavanol-rich extract supplemented beverage compared to a whole apple puree: a randomized, placebo-controlled, crossover trial. Mol Nutr Food Res 57:1209–1217
  • Hur SJ, Lim BO, Decker EA, McClements DJ. 2011. In vitro human digestion models for food applications. Food Chem 125:1–12
  • Kedia G, Vázquez JA, Pandiella SS. 2008. Enzymatic digestion and in vitro fermentation of oat fractions by human Lactobacillus strains. Enzyme Microb Technol 43:355–361
  • Konishi Y, Zhaohui Z, Shimizu M. 2006. Phenolic acids are absorbed from the rat stomach with different absorption rates. J Agric Food Chem 54:7539–7543
  • Lampe JW. 2003. Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J Nutr 133:956S–964S
  • Laurent C, Besançon P, Caporiccio B. 2007. Flavonoids from a grape seed extract interact with digestive secretions and intestinal cells as assessed in an in vitro digestion/Caco-2 cell culture model. Food Chem 100:1704–1712
  • Le Blay G, Rytka J, Zihler A, Lacroix C. 2009. New in vitro colonic fermentation model for Salmonella infection in the child gut. FEMS Microbiol Ecol 67:198–207
  • Lesmes U, Beards EJ, Gibson GR, Tuohy KM, Shimoni E. 2008. Effects of resistant starch type III polymorphs on human colon microbiota and short chain fatty acids in human gut models. J Agric Food Chem 56:5415–5421
  • Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102:11070–11075
  • Li AP, Maurel P, Gomez-Lechon MJ, Cheng LC, Jurima-Romet M. 1997. Preclinical evaluation of drug–drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction. Chem Biol Interact 107:5–16
  • Lotito SB, Frei B. 2006. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med 41:1727–1746
  • Lund EK. 2003. Ethical aspects of human nutritional intervention studies. Pol J Food Nutr Sci 12/53:159–165
  • Macfarlane GT, Macfarlane S. 2007. Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut. Curr Opin Biotechnol 18:156–162
  • Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, et al. 2005. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100:373–382
  • Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, et al. 2006. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55:205–211
  • Mather JP, Roberts PE. 1998. Introduction to cell and tissue culture: theory and technique. Introductory cell and molecular biology techniques. New York and London: Plenum Press
  • Mennigen R. Bruewer M. 2009. Effect of probiotics on intestinal barrier function. Ann NY Acad Sci 1165:183–189
  • Mortensen A, Sorensen IK, Wilde C, Dragoni S, Mullerová D, Toussaint O, Zloch Z, et al. 2008. Biological models for phytochemical research: from cell to human organism. Br J Nutr 99:ES118–ES126
  • Mosele JI, Martin-Pelaez S, Macia A, Farras M, Valls RM, Catalan U, Motilva MJ. 2014. Study of the catabolism of thyme phenols combining in vitro fermentation and human intervention. J Agric Food Chem 62:10954–10961
  • Neilson AP, Sapper TN, Janle EM, Rudolph R, Matusheski NV, Ferruzzi MG. 2010. Chocolate matrix factors modulate the pharmacokinetic behavior of cocoa flavan-3-ol phase II metabolites following oral consumption by Sprague-Dawley rats. J Agric Food Chem 58:6685–6691
  • Nielsen DS, Krych L, Buschard K, Hansen CHF, Hansen AK. 2014. Beyond genetics: influence of dietary factors and gut microbiota on type 1 diabetes. FEBS Lett 588:4234–4243
  • Öbrink KJ, Rehbinde C. 2003. The defined animal. Scand J Lab Anim Sci 20:5–9
  • Ortega N, Reguant J, Romero MP, Macià A, Motilva MJ. 2009. Effect of fat content on the digestibility and bioaccessibility of cocoa polyphenol by an in vitro digestion model. J Agric Food Chem 57:5743–5749
  • Patel J, Aneja K, Tiwari RA. 2010. A review on bioavailability and bioequivalence trials and its necessity. Int J Pharm Sci 2:1–8
  • Payne AN, ZihlerI A, Chassard C, Lacroix C. 2012. Advances and perspectives in in vitro human gut fermentation modeling. Trends Biotechnol 30:17–25
  • Pompei A, Cordisco L, Raimondi S, Amaretti A, Pagnoni UM, Matteuzzi D, Rossi M. 2008. In vitro comparison of the prebiotic effects of two Inulin-type fructans. Anaerobe 14:280–286
  • Possemiers S, Bolca S, Verstraete W, Heyerick A. 2011. The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals. Fitoterapia 82:53–66
  • Rechner AR, Smith MA, Kuhnle G, Gibson GR, Debnam ES, Srai SKS, Moore KP, Rice-Evans CA. 2004. Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic Biol Med 36:212–225
  • Renouf M, Marmet C, Guy PA, Beaumont M, Lepage M, Williamson G, Dionisi F. 2013. Dose–response plasma appearance of green tea catechins in adults. Mol Nutr Food Res 57:833–839
  • Rubió L, Macià A, Castell-Auví A, Pinent M, Blay MT, Ardèvol A, Romero MP, Motilva MJ. 2014a. Effect of the co-occurring olive oil and thyme extracts on the phenolic bioaccesibility and bioavailability assessed by in vitro digestion and cell models. Food Chem 149:277–284
  • Rubió L, Farràs M, de La Torre R, Macià A, Romero MP, Valls RM, Solà R, et al. 2014b. Metabolite profiling of olive oil and thyme phenols after a sustained intake of two phenol-enriched olive oils by humans: identification of compliance markers. Food Res Int 65:59–68
  • Rubió L, Valls RM, Macià A, Pedret A, Giralt M Romero, MP, Motilva MJ. 2012. Impact of olive oil phenolic concentration on human plasmatic phenolic metabolites. Food Chem 135:2922–2929
  • Sambruy Y, Ferruzza S, Ranaldi G, de Angelis I. 2001. Intestinal cell culture models: applications in toxicology and pharmacology. Cell Biol Toxicol 17:301–317
  • Savage GP, Catherwood DJ. 2007. Determination of oxalates in Japanese taro corms using an in vitro digestion assay. Food Chem 105:383–388
  • Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kelm M. 2006. (−)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103:1024–1029
  • Serra A, Bladé C, Arola Ll, Macià A, Motilva MJ. 2013. Flavanol metabolites distribute in visceral adipose depots after a long-term intake of grape seed proanthocyanidin extract in rats. Br J Nutr 110:1411–1420
  • Serra A, Macià A, Romero MP, Anglès N, Morelló JR, Motilva MJ. 2010. Metabolic pathways of the colonic metabolism of procyanidins (monomers and dimers) and alkaloids. Food Chem 126: 1127–1137
  • Serra A, Macià A, Romero MP, Anglès N, Morelló JR, Motilva MJ. 2011. Metabolic pathways of the colonic metabolism of procyanidins (monomers and dimers) and alkaloids. Food Chem 126:1127–1137
  • Serra A, Rubió L, Borrás X, Macià A, Romero MP, Motilva MJ. 2012. Distribution of olive oil phenolic compounds in rat tissues after administration of a phenolic extract from olive cake. Mol Nutr Food Res 56:486–496
  • Souliman S, Beyssac E, Cardot J, Denis S, Alric M. 2007. Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using USP methods and an artificial digestive system. Drug Dev Ind Pharm 33:475–483
  • Souliman S, Blanquet S, Beyssac E, Cardot J. 2006. A Level a in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. Eur J Pharm Sci 27:72–79
  • Spencer JPE, Abd El Mohsen MM, Minihane AM, Mathers JC. 2008. Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr 99:12–22
  • Stahl W, Van Den Berg H, Arthur J, Bast A, Dainty J, Faulks RM, Gartner C, Astley SB. 2002. Bioavailability and metabolism. Mol Asp Med 23:39–100
  • Taleno C, Yoshizane Y, Saito N, Kataoka M, Utoh R, Yamasaki C, Tachibana A, et al. 2004. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 165:901–912
  • Tsang C, Auger C, Mullen W, Bornet A, Rouanet J, Crozier A, Teissedre P. 2005. The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. Br J Nutr 94:170–181
  • Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027–1031
  • Unno T, Tamemoto K, Yayabe F, Kakuda T. 2003. Urinary excretion of 5-(3′,4′-dihydroxyphenyl)-ã-valerolactone, a ring-fission metabolite of (−)-epicatechin, in rats and its in vitro antioxidant activity. J Agric Food Chem 51:6893–6898
  • Valls RM, Soler A, Girona J, Heras M, Romero MP, Covas MI, Solà R, et al. 2010. Effect of the long-term regular intake of virgin olive oil on the phenolic metabolites in human fasting plasma. J Pharm Biomed Anal 53:68–74
  • Versantvoort CHM, Oomen AG, Van de Kamp E, Rompelberg CJM, Sips AJAM. 2005. Applicability of an in vitro digestion model in assessing the bioaccessibility of mycotoxins from food. Food Chem Toxicol 43:31–40
  • Vitaglione P, Barone Lumaga R, Ferracane R, Radetsky I, Mennella I, Schettino R, Koder S, Fogliano V. 2012. Curcumin bioavailability from enriched bread: the effect of microencapsulated ingredients. J Agric Food Chem 60:3357–3366
  • Vitaglione P, Barone Lumaga R, Ferracane R, Sellitto S, Morello JR, Reguant Miranda J, Shimoni E, Fogliano V. 2013. Human bioavailability of flavanols and phenolic acids from cocoa-nut creams enriched with free or microencapsulated cocoa polyphenols. Br J Nutr 109:1832–1843
  • Wilkening S, Stahl F, Bader A. 2003. Comparison of primary human hepatocytes and hepatoma cell line hepG2 with regard to their biotransformation properties. Drug Metab Dispos 31:1035–1042
  • Zamora-Ros R, Rabassa M, Llorach R, Gonzalez CA, Andres-Lacueva C. 2012. Application of dietary phenolic biomarkers in epidemiology: past, present, and future. J Agric Food Chem 60:6648–6657
  • Zihler A, Gagnon M, Chassard C, Hegland A, Stevens MJA, Braegger CP, Lacroix C. 2010. Unexpected consequences of administering bacteriocinogenic probiotic strains for Salmonella populations, revealed by an in vitro colonic model of the child gut. Microbiology 156:3342–3353

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.